Neuro-Oncology
Reviews


Volume 22 Number 8
August 2020


Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 8, August



Contents


Central nervous system tumors


Gliomas


High-grade gliomas


Low-grade gliomas


Diffuse astrocytic and oligodendroglial tumors


Glioblastoma


Diffuse Midline Glioma


Ependymal tumors


Myxopapillary ependymoma


Embryonal tumors


Medulloblastoma


Atypical theratoid/rhabdoid tumor


Meningiomas


Germ cell tumors



Central nervous system tumors

Review

Buday J, Albrecht J, MareÅ¡ T, Podgorná G, HoráÄková K, KaliÅ¡ová L, Raboch J, Anders M.
Brain Tumors and Electroconvulsive Therapy: A Literature Overview of the Last 80 Years.
Front Neurol. 2020 Jul 31. 2020;11:723. doi: 10.3389/fneur.2020.00723. _



Review

Campanella R, Guarnaccia L, Caroli M, Zarino B, Carrabba G, La Verde N, Gaudino C, Rampini A, Luzzi S, Riboni L, Locatelli M, Navone SE, Marfia G.
Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and neuro-oncology department.
J Neurol Sci. 2020 Aug 6. 2020;417:117083. doi: 10.1016/j.jns.2020.117083. _



Review

Chi AS et al, PDQ Adult Treatment Editorial Board.
Adult Central Nervous System Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Aug 14. NCBI Bookshelf NBK65982. _



Review

Dixit KS, Kumthekar PU.
Optimal Management of Corticosteroids in Patients with Intracranial Malignancies.
Curr Treat Options Oncol. 2020 Jul 30. 2020;21(9):77. doi: 10.1007/s11864-020-00771-7. _



Review

Gatto L, Franceschi E, Di Nunno V, Tomasello C, Bartolini C, Brandes AA.
Glioneuronal tumors: clinicopathological findings and treatment options.
Future Neurol. 2020 Jul 3. 2020;15(3). doi: 10.2217/fnl-2020-0003. _



Meeting highlights

Gordon D, Maria BL.
Molecular Advances and Targeted Therapies for Pediatric Central Nervous System Tumors.
J Child Neurol. 2020 Aug 18. 2020;0883073820946892. doi: 10.1177/0883073820946892. _



Retrospective study

Harrup R, White VM, Coory M, Walker R, Anazodo A, Skaczkowski G, Bibby H, Osborn M, Phillips MB, Conyers R, Thompson K, Orme LM, Pinkerton R, Nicholls W.
Treatment and Outcomes for Central Nervous System Tumors in Australian Adolescents and Young Adults: A Population-Based National Study.
J Adolesc Young Adult Oncol. 2020 Aug 26. doi: 10.1089/jayao.2020.0074. _



Review

Holste KG, Orringer DA.
Laser interstitial thermal therapy.
Neurooncol Adv. 2019 Dec 16. 2020;2(1):vdz035. doi: 10.1093/noajnl/vdz035. _



Review

Li X, Li Y, Li S, Li H, Yang C, Lin J.
The role of Shh signalling pathway in central nervous system development and related diseases.
Cell Biochem Funct. 2020 Aug 25. doi: 10.1002/cbf.3582. _



Review

Liu S, Cadoux-Hudson T, Schofield CJ.
Isocitrate dehydrogenase variants in cancer - Cellular consequences and therapeutic opportunities.
Curr Opin Chem Biol. 2020 Aug 8. 2020;57:122-134. doi: 10.1016/j.cbpa.2020.06.012. _



Editorial

Lu VM, Shah AH, Eichberg DG, Luther EM, Shah SS, Komotar RJ, Ivan ME.
Utilizing systematic reviews and meta-analyses effectively to evaluate brain tumor biomarkers.
Biomark Med. 2020 Aug 17. doi: 10.2217/bmm-2020-0209. _



Review

Martinez NL, Khanna O, Farrell CJ.
A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
Chin Clin Oncol. 2020 Aug 17. 2020;cco-20-168. doi: 10.21037/cco-20-168. _



Review

Perla A, Fratini L, Cardoso PS, Nör C, Brunetto AT, Brunetto AL, de Farias CB, Jaeger M, Roesler R.
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential.
Front Cell Dev Biol. 2020 Jul 10. 2020;8:546. doi: 10.3389/fcell.2020.00546. _



Review
Meta-analysis

Rodriguez-Almaraz JE, Chang S, Clarke J, Oberheim-Bush NA, Taylor J, Buerki R, Berger M, Zablotska L, Lobach I, Butowski N.
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumors.
Neurooncol Pract. 2020 Apr 3. 2020;7(4):376-383. doi: 10.1093/nop/npaa013. _



Review

Schreck KC, Patel MP, Wemmer J, Grossman SA, Peters KB.
RAF and MEK inhibitor therapy in adult patients with brain tumors: a case-based overview and practical management of adverse events.
Neurooncol Pract. 2020 Feb 27. 2020;7(4):369-375. doi: 10.1093/nop/npaa006. _



Review

Subramanian S, Ahmad T.
Childhood Brain Tumors.
StatPearls 2020 Aug 10. NCBI Bookshelf NBK535415. _



Gliomas

Review

Al-Kharboosh R, ReFaey K, Lara-Velazquez M, Grewal SS, Imitola J, Quiñones-Hinojosa A.
Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy.
Mayo Clin Proc Innov Qual Outcomes. 2020 Aug 5. 2020;4(4):443-459. doi: 10.1016/j.mayocpiqo.2020.04.006. _



Review

Luo Y, Hou WT, Zeng L, Li ZP, Ge W, Yi C, Kang JP, Li WM, Wang F, Wu DB, Wang RY, Qu BL, Li XF, Wang JJ.
Progress in the study of markers related to glioma prognosis.
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7690-7697. doi: 10.26355/eurrev_202007_22271. _



Review
Meta-analysis

Lei H, To C, Lei U.
Association between fish intake and glioma risk: a systematic review and meta-analysis.
J Int Med Res. 2020 Aug 25. 2020;48(8):300060520939695. doi: 10.1177/0300060520939695. _



Review

Liu Y, Lang F, Chou FJ, Zaghloul KA, Yang C.
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications.
Biomedicines. 2020 Aug 20. 2020;8(9):E294. doi: 10.3390/biomedicines8090294. _



Review

Mesfin FB, Al-Dhahir MA.
Gliomas.
StatPearls. 2020 Aug 10. NCBI Bookshelf NBK441874. _



Review

Sharma A, Graber JJ.
Overview of prognostic factors in adult gliomas.
Ann Palliat Med. 2020 Aug 6. 2020;apm-20-640. doi: 10.21037/apm-20-640. _



Review

Valtorta S, Salvatore D, Rainone P, Belloli S, Bertoli G, Moresco RM.
Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.
Int J Mol Sci. 2020 Aug 6. 2020;21(16):E5631. doi: 10.3390/ijms21165631. _



Review

Wang Y, Chen R, Zhou X, Guo R, Yin J, Li Y, Ma G.
miR-137: A Novel Therapeutic Target for Human Glioma.

Mol Ther Nucleic Acids. 2020 Jun 30. 2020;21:614-622. doi: 10.1016/j.omtn.2020.06.028. _



Review

Xue BZ, Xiang W, Zhang Q, Wang YH, Wang HF, Yi DY, Xiong NX, Jiang XB, Zhao HY, Fu P.
Roles of long non-coding RNAs in the hallmarks of glioma.
Oncol Lett. 2020 Aug 4. 2020;20(4):83. doi: 10.3892/ol.2020.11944?. _



High-grade gliomas


Review

Elleaume H, Barth RF, Rousseau J, Bobyk L, Balosso J, Yang W, Huo T, Nakkula R.
Radiation therapy combined with intracerebral convection-enhanced delivery of cisplatin or carboplatin for treatment of the F98 rat glioma.
J Neurooncol. 2020 Aug 18. doi: 10.1007/s11060-020-03600-x. _



Review

Ghaemmaghami AB, Mahjoubin-Tehran M, Movahedpour A, Morshedi K, Sheida A, Taghavi SP, Mirzaei H, Hamblin MR.
Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis.
Cell Commun Signal. 2020 Aug 3. 2020;18(1):120. doi: 10.1186/s12964-020-00623-9. _



Review

Shin DH, Melnick KF, Tran DD, Ghiaseddin AP.
In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomas.
J Neurooncol. 2020 Aug 5. doi: 10.1007/s11060-020-03557-x. _



Low-grade gliomas


Review

Albuquerque LAF, Almeida JP, de Macêdo Filho LJM, Joaquim AF, Duffau H.
Extent of resection in diffuse low-grade gliomas and the role of tumor molecular signature-a systematic review of the literature.
Neurosurg Rev. 2020 Aug 7. doi: 10.1007/s10143-020-01362-8. _



Diffuse astrocytic and oligodendroglial tumors

Review

Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Astrocytomas Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Aug 13. NCBI Bookshelf NBK65944. _



Review

Lasocki A, Anjari M, Ӧrs Kokurcan S, Thust SC.
Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review.
Neuroradiology. 2020 Aug 25. doi: 10.1007/s00234-020-02532-7. _



Review

Raza IJ, Tingate CA, Gkolia P, Romero L, Tee JW, Hunn MK.
Blood Biomarkers of Glioma in Response Assessment Including Pseudoprogression and Other Treatment Effects: A Systematic Review.
Front Oncol. 2020 Aug 14. doi: 10.3389/fonc.2020.01191. _



Glioblastoma


Review

Balasa A, Serban G, Chinezu R, Hurghis C, Tamas F, Manu D.
The Involvement of Exosomes in Glioblastoma Development, Diagnosis, Prognosis, and Treatment.
Brain Sci. 2020 Aug 13. 2020;10(8):E553. doi: 10.3390/brainsci10080553. _



Review

DeCordova S, Shastri A, Tsolaki AG, Yasmin H, Klein L, Singh SK, Kishore U.
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
Front Immunol. 2020 Jul 17, 2020;11:1402. doi: 10.3389/fimmu.2020.01402. _



Review

de Melo SM, Marta GN, Yan M, Cruz C, Moraes FY, Riera R.
Management of elderly patients with glioblastoma: current status with a focus on the post-operative radiation therapy.
Ann Palliat Med. 2020 Aug 11. 2020;apm-20-768. doi: 10.21037/apm-20-768. _



Review

Di Nunno V, Franceschi E, Tosoni A, Di Battista M, Gatto L, Lamperini C, Minichillo S, Mura A, Bartolini S, Brandes AA.
Treatment of recurrent glioblastoma: state-of-the-art and future perspectives.
Expert Rev Anticancer Ther. 2020 Aug 17. 2020;1-11. doi: 10.1080/14737140.2020.1807949. _



Review

Gallego L, Ceña V.
Potential advancements in the treatment of difficult-to-treat glioblastoma through nanoparticle drug delivery.
Expert Opin Drug Deliv. 2020 Aug 13. doi: 10.1080/17425247.2020.1810015. _



Review

Gedeon PC, Champion CD, Rhodin KE, Woroniecka K, Kemeny HR, Bramall AN, Bernstock JD, Choi BD, Sampson JH.
Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook.
Expert Rev Clin Pharmacol. 2020 Aug 29. doi: 10.1080/17512433.2020.1817737. _



Review

Ghiaseddin AP, Shin D, Melnick K, Tran DD.
Tumor Treating Fields in the Management of Patients with Malignant Gliomas.
Curr Treat Options Oncol. 2020 Jul 30. 2020;21(9):76. doi: 10.1007/s11864-020-00773-5. _



Letter to the editor

Gupta T, Chatterjee A, Patil V.
Extended adjuvant temozolomide in newly-diagnosed glioblastoma: is more less?
Neuro Oncol. 2020 Aug 10. 2020;noaa194. doi: 10.1093/neuonc/noaa194. _



Review

Hotchkiss KM, Sampson JH.
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor.
J Neurooncol. 2020 Aug 19. doi: 10.1007/s11060-020-03598-2. _



Perspective

Kim DS.
Cancer stem cell plasticity in glioblastoma multiforme: a perspective on future directions in oncolytic virotherapy.
Future Oncol. 2020 Aug 2. doi: 10.2217/fon-2019-0606. _



Case report
Review

Li ZG, Zheng MY, Zhao Q, Liu K, Du JX, Zhang SW.
Solitary vertebral metastatic glioblastoma in the absence of primary brain tumor relapse: a case report and literature review.
BMC Med Imaging. 2020 Aug 7. 2020;20(1):89. doi: 10.1186/s12880-020-00488-x. _



Review

Linhares P, Carvalho B, Vaz R, Costa BM.
Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?
Int J Mol Sci. 2020 Aug 13. 2020;21(16):E5809. doi: 10.3390/ijms21165809. _



Review

Sabbagh Q, Andre-Gregoire G, Guevel L, Gavard J.
Vesiclemia: counting on extracellular vesicles for glioblastoma patients.
Oncogene. 2020 Aug 14. doi: 10.1038/s41388-020-01420-x. _



Case report
Review

Shaaban A, Rajeswaran A, Elbadry RG, Haddad R, Al-Bozom I, Ayyad A, Belkhair S.
Spinal metastasis of cerebral Glioblastoma (GBM) with genetic profile: case report and review of literature.
World Neurosurg. 2020 Jul 31. 2020;S1878-8750(20)31685-5. doi: 10.1016/j.wneu.2020.07.163. _



Review

Souberan A, Tchoghandjian A.
Practical Review on Preclinical Human 3D Glioblastoma Models: Advances and Challenges for Clinical Translation.
Cancers (Basel). 2020 Aug 19. 2020;12(9):E2347. doi: 10.3390/cancers12092347. _



Review

Taiarol L, Formicola B, Magro RD, Sesana S, Re F.
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy.
Nanomedicine (Lond). 2020 Jul 31. 2020;15(19):1861-1871. doi: 10.2217/nnm-2020-0132. _



Review
Meta-analysis

Tsakiris C, Siempis T, Alexiou GA, Zikou A, Sioka C, Voulgaris S, Argyropoulou MI.
Differentiation between True Tumor Progression of Glioblastoma and Pseudoprogression using Diffusion-weighted imaging and Perfusion-weighted imaging: A Systematic Review and Meta-analysis.
World Neurosurg. 2020 Aug 7. 2020;S1878-8750(20)31750-2. doi: 10.1016/j.wneu.2020.07.218. _



Review

Yang M, Oh IY, Mahanty A, Jin WL, Yoo JS.
Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives.
Cancers (Basel). 2020 Aug 19. 2020;12(9):E2334. doi: 10.3390/cancers12092334. _



Editorial

Young JS.
Achieving Efficacious Immunotherapy for Patients with Glioblastoma.
Expert Rev Anticancer Ther. 2020 Aug 27. doi: 10.1080/14737140.2020.1814747. _



Review

Wlodarczyk A, Grot D, Stoczynska-Fidelus E, Rieske P.
Gaps and Doubts in Search to Recognize Glioblastoma Cellular Origin and Tumor Initiating Cells.
J Oncol. 2020 Jul 22. 2020;2020:6783627. doi: 10.1155/2020/6783627. _



Review

Zhang X, Deibert CP, Kim WJ, Jaman E, Rao AV, Lotze MT, Amankulor NM.
Autophagy inhibition is the next step in the treatment of glioblastoma patients following the Stupp era.
Cancer Gene Ther. 2020 Aug 5. doi: 10.1038/s41417-020-0205-8. _



Diffuse midline glioma


Case report
Review

Erdman CM, Christie C, Iqbal MO, Mazzola CA, Tomycz L.
The utilization of sodium fluorescein in pediatric brain stem gliomas: a case report and review of the literature.
Childs Nerv Syst. 2020 Aug 11. doi: 10.1007/s00381-020-04857-3. _



Case report
Review

Hashii Y, Oka Y, Kagawa N, Hashimoto N, Saitou H, Fukuya S, Kanegae M, Ikejima S, Oji Y, Ozono K, Tsuboi A, Sugiyama H.
Encouraging Clinical Evolution of a Pediatric Patient With Relapsed Diffuse Midline Glioma Who Underwent WT1-Targeting Immunotherapy: A Case Report and Literature Review.
Front Oncol. 2020 Jul 24. 2020;10:1188. doi: 10.3389/fonc.2020.01188. _



Review

Pellot JE, De Jesus O.
Diffuse Intrinsic Pontine Glioma.

StatPearls. 2020 Aug 10. NCBI Bookshelf NBK560640. _



Review

Ritchey AK et al, PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Aug 13. NCBI Bookshelf NBK65856. _



Review

Cooney TM, Lubanszky E, Prasad R, Hawkins C, Mueller S.
Diffuse midline glioma: review of epigenetics.
J Neurooncol. 2020 Aug 17. doi: 10.1007/s11060-020-03553-1. _



Ependymal tumors



Myxopapillary ependymoma


Case report
Review

Gitto L, Serinelli S, Galbraith K, Williams M, Mirchia K, Galgano MA, Krishnamurthy S, de la Roza G, Viapiano MS, Walker JM, Jour G, Serrano J, DeLorenzo M, Snuderl M, Richardson TE.
Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the Literature.
J Neuropathol Exp Neurol. 2020 Aug 2. 2020;nlaa077. doi: 10.1093/jnen/nlaa077. _



Embryonal tumors



Medulloblastoma


Review

Carrie C, Kieffer V, Figarella-Branger D, Masliah-Planchon J, Bolle S, Bernier V, Laprie A, Supiot S, Leseur J, Habrand JL, Alapetite C, Kerr C, Dufour C, Claude L, Chapet S, Huchet A, Bondiau PY, Escande A, Truc G, Nguyen TD, Pasteuris C, Vigneron C, Muracciole X, Bourdeaut F, Appay R, Dubray B, Colin C, Ferlay C, Dussart S, Chabaud S, Padovani L; French Group of Pediatric Radiotherapy (GFRP) and the French Society of Pediatric Cancers (SFCE).
Exclusive Hyper-fractionated Radiotherapy and reduced boost volume for standard-risk medulloblastoma: pooled analysis of the two French multicentric studies MSFOP98 and MSFOP 2007 and correlation with molecular subgroups.
Int J Radiat Oncol Biol Phys. 2020 Aug 5. 2020:S0360-3016(20)33743-3. doi: 10.1016/j.ijrobp.2020.07.2324. _



Retrospective study

Gendreau JL, Gupta S, Giles TX, Stone CE, Abraham ME, Lindley JG.
A Retrospective Analysis of the Demographics, Treatment, and Survival Outcomes of Patients with Desmoplastic Nodular Medulloblastoma Using the Surveillance, Epidemiology, and End Results (SEER) Database.
Cureus. 2020 Jul 7. 2020;12(7):e9042. doi: 10.7759/cureus.9042. _



Review

Haltom AR, Toll SA, Cheng D, Maegawa S, Gopalakrishnan V, Khatua S.
Medulloblastoma epigenetics and the path to clinical innovation.
J Neurooncol. 2020 Aug 20. doi: 10.1007/s11060-020-03591-9. _



Review

Klein O.
Medulloblastoma - Introduction.
Neurochirurgie. 2020 Aug 28. 2020;S0028-3770(20)30390-8. doi: 10.1016/j.neuchi.2020.07.002; _



Atypical theratoid/rhabdoid tumor


Case report
Review

Greeneway GP, Page PS, Patel V, Ahmed AS.
Atypical teratoid/rhabdoid tumor of the cerebellum in an adult: case report and literature review.
World Neurosurg. 2020 Aug 15. 2020:S1878-8750(20)31846-5. doi: 10.1016/j.wneu.2020.08.079. _



Meningiomas

Review

de Souza MR, Fagundes CF, Rabelo NN, Teixeira MJ, Figueiredo EG.
Association between intracranial aneurysm and meningiomas: An integrative survival Analysis with identification of prognostic factors.
Clin Neurol Neurosurg. 2020 Aug 8. 2020;198:106128. doi: 10.1016/j.clineuro.2020.106128. _



Germ cell tumors

Review

Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Aug 7. NCBI Bookshelf NBK82800. _



bottom